Age-Related Macular Degeneration (AMD) Drugs Market Research 2024: Lucentis, Eylea, Eylea HD, Vabysmo, Syfovre, Ranibizumab, Aflibercept, Faricimab, Biologic, Biosimilar - Global Forecast to 2029
08 nov. 2024 11h26 HE
|
Research and Markets
Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Age-Related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept,...
Wet Age-Related Macular Degeneration Drug Pipeline Research Report 2023
28 nov. 2023 07h33 HE
|
Research and Markets
Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The "Wet Age-Related Macular Degeneration - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This "Wet...
Age-related Macular Degeneration (AMD) Market Research Report 2022
26 juil. 2022 04h58 HE
|
Research and Markets
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "Age-related Macular Degeneration (AMD) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's...
Europe Age-Related Macular Degeneration Market and Competitive Landscape Report 2021
20 sept. 2021 04h38 HE
|
Research and Markets
Dublin, Sept. 20, 2021 (GLOBE NEWSWIRE) -- The "Europe Age-Related Macular Degeneration Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. Europe...
Europe Dry Age-Related Macular Degeneration Markets and Competitive Landscape Report 2021-2026
10 sept. 2021 03h23 HE
|
Research and Markets
Dublin, Sept. 10, 2021 (GLOBE NEWSWIRE) -- The "Europe Dry Age-Related Macular Degeneration Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. ...
Europe Wet Age-Related Macular Degeneration Markets and Competitive Landscape Report 2021 - Forecast to 2026
10 sept. 2021 03h03 HE
|
Research and Markets
Dublin, Sept. 10, 2021 (GLOBE NEWSWIRE) -- The "Europe Wet Age-Related Macular Degeneration Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering....